Dominique Tobbell – författare
Visar alla böcker från författaren Dominique Tobbell. Handla med fri frakt och snabb leverans.
2 produkter
2 produkter
Del 23 - California/Milbank Books on Health and the Public
Pills, Power, and Policy
The Struggle for Drug Reform in Cold War America and Its Consequences
Inbunden, Engelska, 2011
618 kr
Skickas inom 7-10 vardagar
Since the 1950s, the American pharmaceutical industry has been heavily criticized for its profit levels, the high cost of prescription drugs, drug safety problems, and more, yet it has, together with the medical profession, staunchly and successfully opposed regulation. "Pills, Power, and Policy" offers a lucid history of how the American drug industry and key sectors of the medical profession came to be allies against pharmaceutical reform. It details the political strategies they have used to influence public opinion, shape legislative reform, and define the regulatory environment of prescription drugs. Untangling the complex relationships between drug companies, physicians, and academic researchers, the book provides essential historical context for understanding how corporate interests came to dominate American health care policy after World War II.
Del 23 - California/Milbank Books on Health and the Public
Pills, Power, and Policy
The Struggle for Drug Reform in Cold War America and Its Consequences
Häftad, Engelska, 2011
609 kr
Skickas inom 3-6 vardagar
Since the 1950s, the American pharmaceutical industry has been heavily criticized for its profit levels, the high cost of prescription drugs, drug safety problems, and more, yet it has, together with the medical profession, staunchly and successfully opposed regulation. "Pills, Power, and Policy" offers a lucid history of how the American drug industry and key sectors of the medical profession came to be allies against pharmaceutical reform. It details the political strategies they have used to influence public opinion, shape legislative reform, and define the regulatory environment of prescription drugs. Untangling the complex relationships between drug companies, physicians, and academic researchers, the book provides essential historical context for understanding how corporate interests came to dominate American health care policy after World War II.